Detalhe da pesquisa
1.
Men treated with BEACOPP for Hodgkin lymphoma may be at increased risk of testosterone deficiency.
Ann Hematol
; 103(1): 227-239, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37870576
2.
The Genetic Profile of Large B-Cell Lymphomas Presenting in the Ocular Adnexa.
Int J Mol Sci
; 25(6)2024 Mar 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38542066
3.
Outcome of limited-stage peripheral T-Cell lymphoma after CHOP(-like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group.
Am J Hematol
; 98(3): 388-397, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36588403
4.
Mental health among patients with non-Hodgkin lymphoma: A Danish nationwide study of psychotropic drug use in 8750 patients and 43 750 matched comparators.
Am J Hematol
; 97(6): 749-761, 2022 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35298039
5.
Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy.
Blood
; 134(4): 353-362, 2019 07 25.
Artigo
Inglês
| MEDLINE | ID: mdl-31101627
6.
Relapsed/Refractory International Prognostic Index (R/R-IPI): An international prognostic calculator for relapsed/refractory diffuse large B-cell lymphoma.
Am J Hematol
; 96(5): 599-605, 2021 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33661547
7.
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Lancet
; 394(10216): 2271-2281, 2019 12 21.
Artigo
Inglês
| MEDLINE | ID: mdl-31868632
8.
An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome.
Eur J Haematol
; 100(1): 88-97, 2018 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-29064587
9.
Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial.
Br J Haematol
; 196(2): 437-440, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34435356
10.
No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study.
Br J Haematol
; 173(2): 236-44, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26846879
11.
Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma.
Am J Epidemiol
; 182(7): 624-32, 2015 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26346543
12.
A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait.
Br J Haematol
; 169(3): 435-44, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25709094
13.
Utility of interim and end-of-treatment PET/CT in peripheral T-cell lymphomas: A review of 124 patients.
Am J Hematol
; 90(11): 975-80, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26201505
14.
Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma.
Am J Hematol
; 90(11): 1041-6, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26260224
15.
Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features.
Blood Adv
; 8(8): 1946-1957, 2024 Apr 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38324724
16.
Sexual dysfunction is highly prevalent in male survivors of malignant lymphoma.
Sex Med
; 11(2): qfad021, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-37256215
17.
Social inequality in cancer survivorship: Educational differences in health-related quality of life among 27,857 cancer survivors in Denmark.
Cancer Med
; 12(19): 20150-20162, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37772475
18.
Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER Trial.
Hemasphere
; 7(7): e917, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37427145
19.
Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study.
Hemasphere
; 7(7): e904, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37427146
20.
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group.
Lancet Oncol
; 12(11): 1013-22, 2011 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-21940214